Pharmacies - Brazil

Brazil

In Brazil, the revenue in the Pharmacies market is forecasted to reach €24.81bn in 2024.
It is expected to exhibit a compound annual growth rate (CAGR 2024-2029) of 4.31%, resulting in a market volume of €30.64bn by 2029.
Comparing globally, United States is projected to generate the highest revenue of €359.10bn in 2024.
When considering the total population, per person revenues of €114.00 are estimated to be generated in 2024.
The Brazilian pharmacy market is experiencing a surge in demand for natural and alternative healthcare products.

Key regions: United States, China, Germany, Japan, Europe

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Pharmacies market in Brazil has been experiencing significant growth in recent years, driven by a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in Brazil have played a crucial role in the development of the Pharmacies market. Brazilian consumers have shown a growing preference for convenience and accessibility when it comes to healthcare products and services. Pharmacies, with their wide range of products and convenient locations, have become a popular choice for consumers seeking over-the-counter medications, health supplements, and personal care products. Additionally, the increasing focus on preventive healthcare and wellness has also contributed to the demand for pharmacies in Brazil. Trends in the market have further fueled the growth of the Pharmacies market in Brazil. One notable trend is the expansion of pharmacy chains across the country. These chains offer a consistent and standardized shopping experience, attracting customers with their wide product selection, competitive prices, and professional services. Another trend is the integration of pharmacies with healthcare services. Many pharmacies in Brazil now offer additional services such as health consultations, vaccinations, and diagnostic tests, providing customers with a one-stop solution for their healthcare needs. Local special circumstances in Brazil have also influenced the development of the Pharmacies market. The country's large population, coupled with its geographical size, has created a need for a widespread network of pharmacies to ensure accessibility for all citizens. Furthermore, the Brazilian government has implemented policies to promote the expansion of pharmacies in underserved areas, improving access to healthcare products and services for the population. Underlying macroeconomic factors have played a significant role in the growth of the Pharmacies market in Brazil. The country's improving economic conditions, rising disposable incomes, and growing middle class have contributed to increased consumer spending on healthcare products. Additionally, the aging population in Brazil has created a higher demand for pharmaceuticals and healthcare services, further driving the growth of the Pharmacies market. In conclusion, the Pharmacies market in Brazil has experienced significant growth due to customer preferences for convenience and accessibility, market trends such as the expansion of pharmacy chains and integration with healthcare services, local special circumstances including the need for widespread access to pharmacies, and underlying macroeconomic factors such as improving economic conditions and an aging population. As these factors continue to shape the market, the Pharmacies market in Brazil is expected to continue its upward trajectory in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.